Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
U2 small nuclear RNA auxiliary factor 1-like protein 5 (U2AF1L5) is a predicted protein-coding gene in the human genome that is homologous to the well-characterized U2AF1 gene, which encodes a key splicing factor involved in the recognition of the 3' splice site during pre-mRNA processing[1][5]. U2AF1L5 itself is not functionally characterized, and there is no published evidence supporting its involvement in splicing, disease pathology, or therapeutic targeting. Most information available in published resources refers to its paralog U2AF1, which plays a central role in RNA splicing, implicates in various cancers, and interacts with other splicing factors. Because U2AF1L5 is a *predicted* gene (lacking direct experimental evidence), it should not be referenced as a true protein target for therapeutic or diagnostic purposes unless further research clarifies its function.
None reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U2 small nuclear RNA auxiliary factor 1-like protein 5 (U2AF1L5).